Credit Suisse Group AG Reiterates Underperform Rating for AstraZeneca plc


's stock had its "underperform" rating restated by equities researchers at Credit Suisse Group AG in a research note issued to investors on Monday. They presently have a GBX 4,000 target price on the biopharmaceutical company's stock.



from Biotech News